NO862408D0 - Fremgangsmaate for fremstilling av thiazolidin-4(s)-karboksylsyrederivater. - Google Patents

Fremgangsmaate for fremstilling av thiazolidin-4(s)-karboksylsyrederivater.

Info

Publication number
NO862408D0
NO862408D0 NO862408A NO862408A NO862408D0 NO 862408 D0 NO862408 D0 NO 862408D0 NO 862408 A NO862408 A NO 862408A NO 862408 A NO862408 A NO 862408A NO 862408 D0 NO862408 D0 NO 862408D0
Authority
NO
Norway
Prior art keywords
thiazolidine
procedure
preparation
carboxylic acid
acid derivatives
Prior art date
Application number
NO862408A
Other languages
English (en)
Other versions
NO862408L (no
Inventor
Zoltan Gyoergydeak
Istvan Kovacs
Rezsoe Bognar
Geza Horvath
Terezia Mile
Judit Krusper
Ferenc Pusztai
Mariann Fekete
Sandor Jancso
Janos Balint
Ildiko Mihok
Attila Jakab
Andras Jenei
Bela Szende
Original Assignee
Biogal Gyogyszergyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Gyogyszergyar filed Critical Biogal Gyogyszergyar
Publication of NO862408D0 publication Critical patent/NO862408D0/no
Publication of NO862408L publication Critical patent/NO862408L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NO862408A 1985-06-18 1986-06-17 Fremgangsmaate for fremstilling av thiazolidin-4(s)-karboksylsyrederivater. NO862408L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU852388A HU200177B (en) 1985-06-18 1985-06-18 Process for producing thiazolidinecarboxylic acids and pharmaceutical compositions comprising such compounds

Publications (2)

Publication Number Publication Date
NO862408D0 true NO862408D0 (no) 1986-06-17
NO862408L NO862408L (no) 1986-12-19

Family

ID=10959103

Family Applications (1)

Application Number Title Priority Date Filing Date
NO862408A NO862408L (no) 1985-06-18 1986-06-17 Fremgangsmaate for fremstilling av thiazolidin-4(s)-karboksylsyrederivater.

Country Status (21)

Country Link
US (1) US4775675A (no)
EP (1) EP0206197A1 (no)
JP (1) JPS6248672A (no)
KR (1) KR870000312A (no)
CN (1) CN86104085A (no)
AR (1) AR241532A1 (no)
BG (1) BG46457A3 (no)
DD (1) DD259866A5 (no)
DK (1) DK259386A (no)
ES (1) ES8800919A1 (no)
FI (1) FI862608A (no)
GB (1) GB2177089B (no)
GR (1) GR861517B (no)
HU (1) HU200177B (no)
IL (1) IL78942A0 (no)
IN (1) IN165646B (no)
NO (1) NO862408L (no)
PH (1) PH22790A (no)
PL (2) PL149453B1 (no)
PT (1) PT82769B (no)
SU (2) SU1443800A3 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5740492A (en) * 1980-08-22 1982-03-06 Yamanouchi Pharmaceut Co Ltd Novel 2-phenylimidazo 2,1-b benzothiazole derivative
CN1030415A (zh) * 1987-02-20 1989-01-18 山之内制药株式会社 饱和的杂环碳酰胺衍生物和它的制备方法
IT1223565B (it) * 1987-12-21 1990-09-19 Zambon Spa Derivati dell'acido tiazolidin 4 carbossilico ad attivita' farmaceutica
JP2726999B2 (ja) * 1988-06-22 1998-03-11 日研化学株式会社 イミダゾ［２，１−ｂ］ベンゾチアゾール誘導体及び該化合物を有効成分とする抗潰瘍剤
GB9026114D0 (en) * 1990-11-30 1991-01-16 Norsk Hydro As New compounds
ATE144142T1 (de) * 1991-01-10 1996-11-15 Transcend Therapeutics Inc Verwendung von thiazolidin-4-carboxylatderivaten zur behandlung von lungenerkrankungen
US5747459A (en) * 1991-02-04 1998-05-05 Nestec, Ltd. Method for insuring adequate intracellular glutathione in tissue
US5849686A (en) * 1991-03-11 1998-12-15 Creative Biomolecules, Inc. Morphogen-induced liver regeneration
US5214062A (en) * 1992-04-08 1993-05-25 Clintec Nutrition Co. Method and composition for treating immune disorders, inflammation and chronic infections
US5430045A (en) * 1992-04-23 1995-07-04 Free Radical Sciences, Inc. Method of reducing or preventing bone marrow hypoplasia
US5447712A (en) * 1993-12-09 1995-09-05 Free Radical Sciences Method of reducing cyclophosphamide induced hemorrhagic cystitis
US6083966A (en) * 1998-08-31 2000-07-04 University Of Florida Thiazoline acid derivatives
WO2000016763A2 (en) * 1998-09-21 2000-03-30 University Of Florida Research Foundation, Inc. Antimalarial agents
AU5319700A (en) * 1999-06-02 2000-12-18 S. Mbua Ngale Efange Nicotine receptor ligands
AU6676100A (en) 1999-08-17 2001-03-13 University Of Saskatchewan Technologies Inc. Improved treatment for acute physical insult to the central nervous system
WO2005034949A1 (en) * 2003-09-09 2005-04-21 University Of Florida Desferrithiocin derivatives and their use as iron chelators
DE102004021658A1 (de) * 2004-05-03 2005-12-01 Rudy Dr. Susilo Kombinationspräparate enthaltend 2-Methylthiazolidin-2,4-dicarbonsäure
CA2603385C (en) 2005-04-04 2014-07-15 University Of Florida Research Foundation, Inc. Desferrithiocin polyether analogues and uses thereof for treating metal overload, oxidative stress, and neoplastic and preneoplastic conditions
CN104003955A (zh) 2007-03-15 2014-08-27 佛罗里达大学研究基金公司 去铁硫辛聚醚类似物
CN104114170B (zh) 2011-12-16 2021-07-06 佛罗里达大学研究基金会 4′-去铁硫素类似物的用途
EP2968346B1 (en) * 2013-03-15 2024-02-07 Cancer Research Technology, LLC Methods and compositions for gamma-glutamyl cycle modulation
EP3071201A4 (en) 2013-11-22 2017-04-26 University of Florida Research Foundation, Inc. Desferrithiocin analogs and uses thereof
WO2016176343A1 (en) 2015-04-27 2016-11-03 University Of Florida Research Foundation, Incorporated Metabolically programmed metal chelators and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR923562A (fr) * 1946-02-01 1947-07-10 Tube électronique
CH540234A (de) * 1968-09-06 1973-08-15 Degussa Verfahren zur Herstellung von Penicillamin
ES381037A1 (es) * 1969-06-05 1973-07-01 Ferlux Acido tiazolidin dicarboxilico-2,4 y sus derivados y proce-dimiento para su obtencion.
DE2116629A1 (en) * 1971-04-05 1972-10-19 Institutul de Biochimie, Bukarest 4-thiazolidinecarboxylic acid derivs - with in vivo thiol liberating activity
CA962269A (en) * 1971-05-05 1975-02-04 Robert E. Grahame (Jr.) Thiazoles, and their use as insecticides
US3947464A (en) * 1972-07-28 1976-03-30 Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler Salts of phenylpropanolamine with thiazolidine carboxylic acids
DE2446100C3 (de) * 1974-09-26 1982-01-14 Ludwig Merckle Kg Chem. Pharm. Fabrik, 7902 Blaubeuren Phenoxyalkancarbonsäureamide von Thiazolidincarbonsäuren, Verfahren zu ihrer Herstellung und Arzneimittel
GB1473752A (en) * 1975-04-09 1977-05-18 Rexolin Chem Ab Composition of nitrofurans and its use in controlling formation of slime
FR2356423A1 (fr) * 1976-07-01 1978-01-27 Oeriu Simion Derives de l'acide thiazolidinecarboxylique, leur preparation et leur application comme medicaments
DE3170401D1 (en) * 1980-07-28 1985-06-13 Ciba Geigy Ag Triazoline derivatives and processes for their preparation

Also Published As

Publication number Publication date
FI862608A (fi) 1986-12-19
BG46457A3 (en) 1989-12-15
HUT41774A (en) 1987-05-28
NO862408L (no) 1986-12-19
PL148541B1 (en) 1989-10-31
GB2177089B (en) 1989-07-19
HU200177B (en) 1990-04-28
KR870000312A (ko) 1987-02-17
DD259866A5 (de) 1988-09-07
SU1443800A3 (ru) 1988-12-07
ES8800919A1 (es) 1987-12-01
DK259386A (da) 1986-12-19
PT82769A (en) 1986-07-01
PH22790A (en) 1988-12-12
GR861517B (en) 1986-10-10
FI862608A0 (fi) 1986-06-18
JPS6248672A (ja) 1987-03-03
ES556135A0 (es) 1987-12-01
US4775675A (en) 1988-10-04
GB8614616D0 (en) 1986-07-23
IN165646B (no) 1989-12-02
SU1475905A1 (ru) 1989-04-30
PT82769B (pt) 1988-04-21
IL78942A0 (en) 1986-09-30
AR241532A1 (es) 1992-08-31
PL149453B1 (en) 1990-02-28
DK259386D0 (da) 1986-06-02
EP0206197A1 (de) 1986-12-30
GB2177089A (en) 1987-01-14
CN86104085A (zh) 1987-04-22

Similar Documents

Publication Publication Date Title
NO862408D0 (no) Fremgangsmaate for fremstilling av thiazolidin-4(s)-karboksylsyrederivater.
NO863061D0 (no) Fremgangsmaate for fremstilling av fysiologisk aktive fenoksyeddiksyrederivater.
NO864425D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklyloksoftalazinyl-eddiksyre-derivater.
NO820287L (no) Fremgangsmaate for fremstilling av isocyanursyre-derivater
NO861956L (no) Fremgangsmaate for fremstilling av askorbinsyrederivater.
NO890921D0 (no) Fremgangsmaate for fremstilling av aminosyrederivater.
NO865013D0 (no) Fremgangsmaate for fremstilling av antibaktercelle kinolon-derivater.
NO873689D0 (no) Fremgangsmaate til fremstilling av benzosyrederivater.
NO163453C (no) Fremgangsmaate for fremstilling av sphingosinderivater.
NO880910D0 (no) Fremgangsmaate for fremstilling av chromonderivater.
NO883046L (no) Fremgangsmaate til fremstilling av chinolonkarboksylsyrer.
NO884153L (no) Fremgangsmaate for fremstilling av fenoksyftalsyreanhydrider.
NO860429L (no) Fremgangsmaate for fremstilling av imidazolyl-indol-derivater.
NO864525D0 (no) Fremgangsmaate ved fremstilling av aryleddiksyrederivater.
NO169231C (no) Fremgangsmaate ved fremstilling av karboksylsyreamider.
NO852796L (no) Fremgangsmaate for fremstilling av nitroapovincamin-syrederivater.
NO885446L (no) Fremgangsmaate for fremstilling av kinolincarboxylsyrer.
NO891919D0 (no) Fremgangsmaate for fremstilling av nye karboksylsyrederivater.
NO901687D0 (no) Fremgangsmaate for fremstilling av thiazetokinolin-3-carboxylsyrederivater.
NO903967D0 (no) Fremgangsmaate for fremstilling av dihydrocaffeinsyrederivater.
NO862493D0 (no) Fremgangsmaate for fremstilling av 2-halonicergolinderivater.
NO863005D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4,5,6,7,8-heksahydro-2-alkyl-4-aryl-5-okso-1,7-naftyridin-3-karboksylsyreesterderivater.
NO884100L (no) Fremgangsmaate for fremstilling av halogentiazolderivater.
NO890778D0 (no) Fremgangsmaate for fremstilling av kinolincarboxylsyrederivater.
NO882493D0 (no) Fremgangsmaate for fremstillng av kinolincarboxylsyrederivater.